Electronic Resource
[s.l.]
:
Nature Publishing Group
Nature biotechnology
23 (2005), S. 903-903
ISSN:
1546-1696
Source:
Nature Archives 1869 - 2009
Topics:
Biology
,
Process Engineering, Biotechnology, Nutrition Technology
Notes:
[Auszug] BiDil is a recently approved therapy indicated for congestive heart failure patients already taking standard treatments. It is not a new drug. It is a combination of two existing drugs—isosorbide dinitrate and hydralazine—already marketed seperately as generics. What is new about BiDil ...
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1038/nbt0805-903
Permalink
|
Location |
Call Number |
Expected |
Availability |